Glioma, glutamate (SLC7A11) and seizures-a commentary

Affiliations

¹ Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bangalore, India.
² Department of Clinical Neurosciences, National Institute of Mental Health and Neurosciences, Bangalore, India.

Editorial

Vani Santosh et al. Ann Transl Med. 2017 May.

. 2017 May;5(10):214.

doi: 10.21037/atm.2017.02.18.

¹ Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bangalore, India.
² Department of Clinical Neurosciences, National Institute of Mental Health and Neurosciences, Bangalore, India.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.
Robert SM, Buckingham SC, Campbell SL, Robel S, Holt KT, Ogunrinu-Babarinde T, Warren PP, White DM, Reid MA, Eschbacher JM, Berens ME, Lahti AC, Nabors LB, Sontheimer H. Robert SM, et al. Sci Transl Med. 2015 May 27;7(289):289ra86. doi: 10.1126/scitranslmed.aaa8103. Sci Transl Med. 2015. PMID: 26019222 Free PMC article.

1. Buckingham SC, Campbell SL, Haas BR, et al. Glutamate release by primary brain tumors induces epileptic activity. Nat Med 2011;17:1269-74. 10.1038/nm.2453 - DOI - PMC - PubMed
1. Huang W, Choi W, Chen Y, et al. A proposed role for glutamine in cancer cell growth through acid resistance. Cell Res 2013;23:724-7. 10.1038/cr.2013.15 - DOI - PMC - PubMed
1. Sontheimer H. A role for glutamate in growth and invasion of primary brain tumors. J Neurochem 2008;105:287-95. 10.1111/j.1471-4159.2008.05301.x - DOI - PMC - PubMed
1. Takano T, Lin JH, Arcuino G, et al. Glutamate release promotes growth of malignant gliomas. Nat Med 2001;7:1010-5. 10.1038/nm0901-1010 - DOI - PubMed
1. Noch E, Khalili K. Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity. Cancer Biol Ther 2009;8:1791-7. 10.4161/cbt.8.19.9762 - DOI - PMC - PubMed